AKR1C4 and breast cancer: These four compounds have potential value seen from the Pa value against breast cancer-related receptors HIF1A expression and Chlordecone reductase and followed by a predicted LD50 value of >1000 or toxicity class of >4, and fulfill the Lipinski Rule with the information “Accepted” as shown in Table 2.